<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81083</article-id><article-id pub-id-type="doi">10.7554/eLife.81083</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-283768"><name><surname>Cordova</surname><given-names>Ricardo A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283769"><name><surname>Misra</surname><given-names>Jagannath</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283770"><name><surname>Amin</surname><given-names>Parth H</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283771"><name><surname>Klunk</surname><given-names>Anglea J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283772"><name><surname>Damayanti</surname><given-names>Nur P</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283773"><name><surname>Carlson</surname><given-names>Kenneth R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283774"><name><surname>Elmendorf</surname><given-names>Andrew J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283775"><name><surname>Kim</surname><given-names>Hyeong-Geug</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283776"><name><surname>Mirek</surname><given-names>Emily T</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-290328"><name><surname>Elzey</surname><given-names>Bennet D</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283777"><name><surname>Miller</surname><given-names>Marcus J</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283778"><name><surname>Dong</surname><given-names>X Charlie</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283779"><name><surname>Cheng</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-204168"><name><surname>Anthony</surname><given-names>Tracy G</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283780"><name><surname>Pili</surname><given-names>Robero</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16558"><name><surname>Wek</surname><given-names>Ronald C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283138"><name><surname>Staschke</surname><given-names>Kirk A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8722-9585</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry and Molecular Biology</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Melvin and Bren Simon Comprehensive Cancer Center</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Nutritional Sciences</institution>, <institution>Rutgers, The State University of New Jersey</institution>, <addr-line><named-content content-type="city">New Brunswick</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">5Department of Comparative Pathology</institution>, <institution>Purdue University West Lafayette</institution>, <addr-line><named-content content-type="city">West Lafayette</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>Indiana University School of Medicine</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">1Department of Biochemistry and Molecular Biology</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Jacobs School of Medicine and Biomedical Sciences</institution>, <institution>University at Buffalo, State University of New York</institution>, <addr-line><named-content content-type="city">Buffalo</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-63658"><name><surname>Sharifi</surname><given-names>Nima</given-names></name><role>Reviewing editor</role><aff><institution>Cleveland Clinic</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>rpili@buffalo.edu</email> (RP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>rwek@iu.edu</email> (RW);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>kastasch@iu.edu</email> (KS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>09</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e81083</elocation-id><history><date date-type="received"><day>15</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>14</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Cordova et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Cordova et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81083-v1.pdf"/><abstract><p>A stress adaptation pathway termed the integrated stress response has been suggested to be active in many cancers including prostate cancer (PCa). Here, we demonstrate that the eIF2 kinase GCN2 is required for sustained growth in androgen-sensitive and castration-resistant models of PCa both in vitro and in vivo, and is active in PCa patient samples. Using RNA-seq transcriptome analysis and a CRISPR-based phenotypic screen, GCN2 was shown to regulate expression of over 60 solute-carrier (<italic>SLC</italic>) genes, including those involved in amino acid transport and loss of GCN2 function reduces amino acid import and levels. Addition of essential amino acids or expression of 4F2 (SLC3A2) partially restored growth following loss of GCN2, suggesting that GCN2 targeting of SLC transporters is required for amino acid homeostasis needed to sustain tumor growth. A small molecule inhibitor of GCN2 showed robust in vivo efficacy in androgen-sensitive and castration-resistant mouse models of PCa, supporting its therapeutic potential for the treatment of PCa.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>GM136331</award-id><principal-award-recipient><name><surname>Wek</surname><given-names>Ronald C</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>DK109714</award-id><principal-award-recipient><name><surname>Anthony</surname><given-names>Tracy G</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R21CA221942</award-id><principal-award-recipient><name><surname>Pili</surname><given-names>Robero</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Indiana University Melvin and Bren Simon Comprehensive Cancer Center</institution></institution-wrap></funding-source><award-id>P30CA082709</award-id><principal-award-recipient><name><surname>Staschke</surname><given-names>Kirk A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Tracy G Anthony, is a consultant for HiberCell, Inc..</p></fn><fn fn-type="conflict" id="conf3"><p>Ronald C Wek, is a member of the advisory board and holds equity in HiberCell, Inc..</p></fn><fn fn-type="conflict" id="conf4"><p>Kirk A Staschke, is a consultant for HiberCell, Inc. and receives research support from HiberCell, Inc..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) at Indiana University School of Medicine (Protocol #21014) and comply with all regulations for ethical conduct of animal research. Human prostate core needle biopsy specimens were obtained from the Indiana University Comprehensive Cancer Center Tissue Procurement and Distribution Core and approval was granted by the Institutional Review Board (IRB #1796) at the Office of Research Administration at Indiana University.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The authors declare that all data generated or analyzed in this study are included in the published article, its supplementary information and source files, or are publicly available. The CHARGE-seq and RNA-seq datasets generated in this study have been deposited in the NCBI Gene Expression Omnibus (GEO) database under the ascension codes GSE196251 and GSE196252, respectively. The custom python script used in the analysis of our Charge-seq study is available on GitHub (https://github.com/carlsonkPhD/tRNA_Charge-Seq/). Gene expression data from prostate cancer patients (PRAD) in the TCGA database used for correlation analysis is publicly available.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Cordova RA</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196251">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196251</ext-link><comment>NCBI Gene Expression Omnibus, GSE196251</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Cordova RA</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>GCN2 eIF2 kinase promotes prostate cancer by maintaining amino acid homeostasis</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196252">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196252</ext-link><comment>NCBI Gene Expression Omnibus, GSE196252</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-81083-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>